Streetbeat News

Analyst Ratings

LILM

In the last quarter, Lilium (NASDAQ:LILM) received 3 bullish and 2 indifferent analyst ratings. The company's average 12-month price target is $2.26, with a high of $3.00 and a low of $1.10. This average price target has increased by 100.0% over the past month.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:00 pm

G

Over the past 3 months, 7 analysts have published their opinion on Genpact (NYSE:G) stock. The average price target is $43.29, implying an upside from the current price of $36.16. However, this average has decreased by 10.74% from the previous average price target of $48.50.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:00 pm

DOC

Citigroup analyst Michael Bilerman maintains a Neutral rating on Physicians Realty Trust (NYSE:DOC) and lowers the price target from $15 to $14.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 3:00 pm

AFRM

Over the last quarter, Affirm Holdings (NASDAQ:AFRM) has received various analyst ratings, with 3 being bullish, 1 somewhat bullish, 4 indifferent, 1 somewhat bearish, and 1 bearish. The average price target given by these analysts is $16.85, compared to Affirm's current price of $14.475, implying an upside. This average price target has increased by 6.44% over the past month.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:00 pm

VZ

Over the past 3 months, 8 analysts have published their opinion on Verizon Communications (NYSE:VZ) stock. The analysts have an average price target of $40.38 versus the current price of Verizon Communications at $33.07, implying upside. This current average represents a 7.17% decrease from the previous average price target of $43.50.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:00 pm

PRTA

Analysts have provided bullish and somewhat bullish ratings for Prothena Corp (NASDAQ:PRTA) in the last quarter. In the last 3 months, 9 analysts have offered 12-month price targets for Prothena Corp with an average price target of $110.0, an increase of 34.15% from the previous average price target of $82.00.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:00 pm

ESS

Citigroup analyst Michael Bilerman maintains a Buy rating on Essex Property Trust (NYSE:ESS) and raises the price target from $250 to $280.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 2:59 pm

HR

Citigroup analyst Michael Griffin maintains a Neutral rating on Healthcare Realty Trust (NYSE:HR) and lowers the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 2:57 pm

CTRN

Citi Trends, Inc.'s Q2 FY23 sales decreased by 6.2% YoY to $173.55 million, beating the analyst consensus estimate of $165.57 million. The adjusted EPS loss of 60 cents also beat the analyst consensus estimate of a 97-cent loss. The company reiterated its FY23 sales guidance and plans to open five new stores, remodel 10 to 20 stores, and close 10 to 15 underperforming stores in the year. Citi Trends shares were up 7.67% at $23.73 Tuesday morning.

Portfolio Pulse from Nabaparna Bhattacharya

August 22, 2023 | 2:57 pm

LILM

Citigroup analyst Itay Michaeli has maintained a Neutral rating on Lilium (NASDAQ:LILM) and raised the price target from $1 to $1.1.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 2:56 pm